Pregnolia, a Spinoff company from ETH Zurich, is offering a CE-marked medical device that enables a step-change in improving the gold standard to detect the risk of preterm birth. The device measures the stiffness of the uterine cervix. By assessing cervical stiffness, doctors can double the sensitivity from 40% to 80%, which means 8 out of 10 women at risk can be detected....
Pregnolia, a Spinoff company from ETH Zurich, is offering a CE-marked medical device that enables a step-change in improving the gold standard to detect the risk of preterm birth. The device measures the stiffness of the uterine cervix. By assessing cervical stiffness, doctors can double the sensitivity from 40% to 80%, which means 8 out of 10 women at risk can be detected.
More information

Employees

Sabrina Badir
Admin
Sabrina Badir CEO Sabrina Badir is a biomechanics enineer, CEO & Founder of Pregnolia, a Spinoff of ETH Zürich.